Timothy Williams

Insider Reports History

Entity
Individual
Location
C/O Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue Nw, Suite 300 E, Washington, DC
Signature
/s/ Timothy Williams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Williams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. SVP & General Counsel Common Stock 197K $823K $4.18 Mar 5, 2024 Direct

Insider Reports Filed by Timothy Williams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VNDA Vanda Pharmaceuticals Inc. Mar 4, 2024 2 -$73.3K 4 Mar 6, 2024 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Feb 16, 2024 1 $0 4 Feb 21, 2024 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Jun 13, 2023 1 -$95.8K 4 Jun 15, 2023 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Mar 2, 2023 2 -$105K 4 Mar 6, 2023 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Feb 16, 2023 2 $0 4 Feb 21, 2023 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Dec 15, 2022 1 -$56.1K 4 Dec 16, 2022 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Aug 15, 2022 2 -$85.5K 4 Aug 17, 2022 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Feb 28, 2022 3 -$134K 4 Mar 2, 2022 SVP & General Counsel
VNDA Vanda Pharmaceuticals Inc. Aug 16, 2021 1 -$60K 4 Aug 17, 2021 SVP & General Counsel